Conflans Sainte Honorine, France

Helene Guillemain

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helene Guillemain. Retrieved from https://idiyas.com/inventor/helene-guillemain

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal1 out of 834,771 
Other
 patents

Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Helene Guillemain: Innovator in Medical Treatments

Introduction

Helene Guillemain is a notable inventor based in Conflans Sainte Honorine, France. She has made significant contributions to the field of medical treatments, particularly in addressing conditions linked to excessive effects of TNF-alpha.

Latest Patents

Helene holds a patent for a benzene sulphonamide compound, which is utilized in the treatment of pathological conditions associated with an excessive effect of TNF-alpha. This innovative compound is designed to act as a direct inhibitor of TNF-alpha, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Helene has demonstrated a strong dedication to research and development in the pharmaceutical field. Her work has led to the creation of effective treatments that can improve the quality of life for patients suffering from various conditions.

Collaborations

Helene has collaborated with esteemed colleagues such as Jean-Francois Zagury and Matthieu Montes. These partnerships have further enriched her research and contributed to the success of her innovative projects.

Conclusion

Helene Guillemain's contributions to medical treatments through her patent and collaborations highlight her role as a significant innovator in the field. Her work continues to inspire advancements in healthcare and treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…